Literature DB >> 24662370

Evaluation of quetiapine abuse and misuse reported to poison centers.

Wendy Klein-Schwartz1, Elana K Schwartz, Bruce D Anderson.   

Abstract

OBJECTIVE: There are case reports of abuse of quetiapine, but no studies address quetiapine abuse or misuse. Most literature on the population that abuses quetiapine describes an older age group with previous substance abuse history, many of whom are in jail. The objective of this study was to evaluate national poison center data on misuse/abuse of quetiapine.
METHODS: A retrospective study of American Association of Poison Control Centers National Poison Data System data from 2005 to 2011 on single substance quetiapine exposures coded as intentional misuse or abuse and followed to known outcome was performed. Data were evaluated for age, toxicity, management sites, treatments, and medical outcomes.
RESULTS: There were 3116 cases meeting inclusion criteria; reason was misuse in 1948 cases and abuse in 1168 cases. The median age was 23 years. Misuse was reported most often in adults, whereas abuse occurred most frequently in adolescents. The male-to-female ratio was 1.7 for abuse and 1.0 for misuse. There were no deaths. Moderate or major toxicity occurred in 23.7% and 27.1% of misuse and abuse cases, respectively. Seventy-six percent were treated in the emergency department and/or received medical admission.
CONCLUSIONS: Misuse was more common than abuse, except in adolescents for whom abuse was more frequent. Although outcomes were generally good, significant toxicity occurred in 25% of cases and more than 75% of the patients were treated in the emergency department and/or received medical admission. The consequences of nonmedical use of quetiapine are serious in some patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24662370     DOI: 10.1097/ADM.0000000000000020

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  7 in total

1.  Novel psychoactive substances of interest for psychiatry.

Authors:  Fabrizio Schifano; Laura Orsolini; G Duccio Papanti; John M Corkery
Journal:  World Psychiatry       Date:  2015-02       Impact factor: 49.548

2.  Evaluation of the Reinforcing Effect of Quetiapine, Alone and in Combination with Cocaine, in Rhesus Monkeys.

Authors:  Robert E Brutcher; Susan H Nader; Michael A Nader
Journal:  J Pharmacol Exp Ther       Date:  2015-12-07       Impact factor: 4.030

3.  Prevalent intravenous abuse of methylphenidate among treatment-seeking patients with substance abuse disorders: a descriptive population-based study.

Authors:  Gudrun D Bjarnadottir; Haraldur M Haraldsson; Bjarni O Rafnar; Engilbert Sigurdsson; Steinn Steingrimsson; Magnus Johannsson; Helena Bragadottir; Andres Magnusson
Journal:  J Addict Med       Date:  2015 May-Jun       Impact factor: 3.702

4.  Intentional Recreational Abuse of Quetiapine Compared to Other Second-generation Antipsychotics.

Authors:  Lauren Klein; Stacey Bangh; Jon B Cole
Journal:  West J Emerg Med       Date:  2016-12-06

5.  Comparison of Quetiapine Abuse and Misuse Reports to the FDA Adverse Event Reporting System With Other Second-Generation Antipsychotics.

Authors:  Kirk E Evoy; Chengwen Teng; Victor G Encarnacion; Brian Frescas; John Hakim; Stephen Saklad; Christopher R Frei
Journal:  Subst Abuse       Date:  2019-05-01

Review 6.  Competent psychopharmacology.

Authors:  David M Gardner
Journal:  Can J Psychiatry       Date:  2014-08       Impact factor: 4.356

7.  Quetiapine, Misuse and Dependency: A Case-Series of Questions to a Norwegian Network of Drug Information Centers.

Authors:  Jan Anker Jahnsen; Sofia Frost Widnes; Jan Schjøtt
Journal:  Drug Healthc Patient Saf       Date:  2021-07-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.